Maxime Cordonnier
Director Financiero/CFO en AFYREN .
Cargos activos de Maxime Cordonnier
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AFYREN | Director Financiero/CFO | 01/01/2019 | - |
Contacto de Relaciones con Inversores | - | - |
Historial de carrera de Maxime Cordonnier
Antiguos cargos conocidos de Maxime Cordonnier.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Evertree SAS
Evertree SAS Chemicals: SpecialtyProcess Industries Evertree SAS produces plant-based chemicals. Its product SynerXiD is a family of proprietary, dry powder chemicals for industrial manufacturing. The company was founded by Anthony Parker and Joe Marcinko on February 16, 2016 and is headquartered in Compiegne, France. | Director/Miembro de la Junta | 01/12/2016 | 01/12/2018 |
Yposkesi
Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | Director/Miembro de la Junta | 01/11/2016 | 01/06/2018 |
Carbiolice SAS
Carbiolice SAS Miscellaneous ManufacturingProducer Manufacturing Carbiolice SAS engages in the provision of biological technologies for plastics and synthetic fibers. The company was founded on June 14, 2016 and is headquartered in Riom, France. | Director/Miembro de la Junta | 01/09/2016 | 01/06/2018 |
Lundbeck SAS
Lundbeck SAS Pharmaceuticals: MajorHealth Technology Lundbeck SAS is a pharmaceutical laboratory, which focuses on neurology and psychiatry. The company was founded in 1992 and is headquartered in Paris La Defense, France. | Corporate Officer/Principal | 01/11/2009 | 01/12/2010 |
Formación de Maxime Cordonnier.
Imperial College London | Graduate Degree |
École Centrale Paris | Undergraduate Degree |
Estadísticas
Internacional
Francia | 7 |
Reino Unido | 2 |
Operativa
Director/Board Member | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Producer Manufacturing | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AFYREN | Health Technology |
Empresas privadas | 4 |
---|---|
Lundbeck SAS
Lundbeck SAS Pharmaceuticals: MajorHealth Technology Lundbeck SAS is a pharmaceutical laboratory, which focuses on neurology and psychiatry. The company was founded in 1992 and is headquartered in Paris La Defense, France. | Health Technology |
Carbiolice SAS
Carbiolice SAS Miscellaneous ManufacturingProducer Manufacturing Carbiolice SAS engages in the provision of biological technologies for plastics and synthetic fibers. The company was founded on June 14, 2016 and is headquartered in Riom, France. | Producer Manufacturing |
Evertree SAS
Evertree SAS Chemicals: SpecialtyProcess Industries Evertree SAS produces plant-based chemicals. Its product SynerXiD is a family of proprietary, dry powder chemicals for industrial manufacturing. The company was founded by Anthony Parker and Joe Marcinko on February 16, 2016 and is headquartered in Compiegne, France. | Process Industries |
Yposkesi
Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Maxime Cordonnier
- Experiencia